Inherited TP53 Variants and Risk of Prostate Cancer
2021 · European Urology · 86 citations
https://doi.org/10.1016/j.eururo.2021.10.036
M
Maria I. Carlo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
261
Papers
7.6K
Citations
41
h-index
84
i10-index
Maria I. Carlo is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Genomics and Diagnostics & Renal and related cancers. The author has an h-index of 41, co-authored 222 publications.
ORCID: 0000-0002-4786-7408Papers by this author
worksComprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
2022 · Annals of Oncology · 51 citations
https://doi.org/10.1016/j.annonc.2022.01.006
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2022 · Cancer Epidemiology Biomarkers & Prevention · 29 citations
https://doi.org/10.1158/1055-9965.epi-21-1287
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
2022 · European Urology Focus · 24 citations
https://doi.org/10.1016/j.euf.2021.12.002
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
2023 · Cell Metabolism · 21 citations
https://doi.org/10.1016/j.cmet.2023.06.005
The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing
2020 · Cancer Treatment and Research Communications · 20 citations
https://doi.org/10.1016/j.ctarc.2020.100165
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat